4//SEC Filing
Lenz Robert A. 4
Accession 0001610717-24-000063
CIK 0001885522other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 4:13 PM ET
Size
7.3 KB
Accession
0001610717-24-000063
Insider Transaction Report
Form 4
Lenz Robert A.
Head of R&D
Transactions
- Award
Common Stock
2024-02-14+50,000→ 402,941 total - Award
Stock Option (Right to Buy)
2024-02-14+100,000→ 100,000 totalExercise: $18.07Exp: 2034-02-13→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 25% of the RSUs vest annually measured from February 14, 2024 (the "Vesting Commencement Date"), such that 100% of the RSUs will be fully vested on the fourth anniversary of the Vesting Commencement Date.
- [F2]25% of the shares subject to the option vest on the first anniversary measured from February 14, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
Documents
Issuer
Neumora Therapeutics, Inc.
CIK 0001885522
Entity typeother
Related Parties
1- filerCIK 0001992908
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 4:13 PM ET
- Size
- 7.3 KB